Home

Nectar Lifesciences Limited

NECLIFE.NSNSEHealthcare
₹10.79Today0.55% · -₹0.06
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹10.85
AskWarren SignalsUpdated 00:06 IST
Momentum Bearish(-0.55% today)Volume 87% Below Avg52W Position Near 52W Low
Volume
70.3K
87% below avg
Avg vol (20D)
5.4L
20-day baseline
Mkt cap
₹209.8Cr
Small Cap
P/E TTM
0.0×

Trade Nectar Lifesciences Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and internationally. The company offers cephalosporins, includes pharmaceutical ingredients and intermediates comprising cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also provides contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company offers menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Stock ExchangeNSE

Identifiers

Ticker SymbolNECLIFE.NS

Company Info

HeadquartersNot available
Employees0
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.

Nectar Lifesciences Limited (NECLIFE) Stock Price & Analysis | Artha